Health Care: Drugs

Coronado Biosciences Inc (CNDO: NASDAQ)

$1.7 n/a | n/a%
07/21/14 - 03:59 PM ET
Company Cash Flow
Dec 2013 Dec 2012 Dec 2011
Cash Flow From Operating Activities
Net Income (Loss) -37.16M -27.61M -36.36M
Operating Gains/Losses 0.00 0.00 0.00
Extraordinary Gains / Losses 0.00 0.00 0.00
(Increase) Decrease In Receivables 0.00 0.00 0.00
(Increase) Decrease in Inventories 0.00 0.00 0.00
(Increase) Decrease In Other Current Assets 0.00 0.00 -160.00K
(Decrease) Increase In Payables 1.18M -260.00K 1.92M
(Decrease) Increase In Other Current Liabilities -10.00K 100.00K 19.00K
(Increase) Decrease In Other Working Capital 0.00 0.00 0.00
Other Non-Cash Items 6.44M 4.81M 23.63M
Net Cash From Continuing Operations -29.65M -23.19M -10.95M
Net Cash From Discontinued Operations 0.00 0.00 0.00
Cash Provided By Investing Activities
Net Cash From Total Operating Activities -29.65M -23.19M -10.95M
Sale of Property, Plant & Equipment 0.00 0.00 0.00
Cash Used for Investing Activities
Sale of Short-Term Investments 0.00 0.00 0.00
Purchases of Property, Plant & Equipment -188.00K -279.00K -3.84M
Acquisitions 0.00 0.00 0.00
Purchases of Short-Term Investments 0.00 0.00 0.00
Other Cash from Investing Activities 0.00 0.00 0.00
Cash Provided by Financing Activities
Net Cash From Investing Activities -188.00K -279.00K -3.84M
Issuance of Debt 0.00 15.00M 0.00
Cash Used for Financing Activities
Issuance of Capital Stock 92.40M 28.86M 25.98M
Repayment of Long-Term Debt -1.34M -750.00K 0.00
Repurchase of Capital Stock -1.90M -2.30M -2.88M
Payment of Cash Dividends 0.00 0.00 0.00
Other Financing Charges, Net 0.00 -288.00K 0.00
Net Cash From Financing Activities 89.16M 40.51M 23.09M
Effect of Exchange Rate Changes 0.00 0.00 0.00
Net Change in Cash & Cash Equivalents 59.32M 17.04M 8.30M

Portfolios with CNDO

Latest CNDO Headlines from TheStreet

More Financial News for CNDO

Press Releases for CNDO

See All Press Releases
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter